Arthur Makadi, Strategic Projects Coordinator, shares his experience since joining the Pharmalys team

May 20, 2024 | Non classé

In April 2024, I embarked on a pivotal journey as the Strategic Projects Coordinator at Pharmalys, an organisation recognised for its commitment to advancing global health through clinical research conducted in adherence to international guidelines and high-quality standards. Joining Pharmalys was not just a career move but a strategic decision aligned with my professional ethos and commitment to elevating clinical research standards worldwide. Since its inception in 2008, Pharmalys has significantly increased its expertise in research projects and expanded collaborations across Europe and Africa. The company has worked with various organisations, including pharmaceutical companies, non-governmental organisations, and institutional structures, cultivating strong professional ties with Key Opinion Leaders, Principal Investigators, and clinical research site staff. Pharmalys’ vision of ‘a world free of unnecessary suffering due to unmet health care needs’ profoundly resonates with my personal and professional ideals, motivating me to make meaningful contributions to this cause.

Advancing Global Health through Research

For me, Pharmalys is a pioneer in clinical research, committed to pushing boundaries and making a real difference. Our dedication to upholding the highest international standards, as well as our commitment to seeking new technologies in our domain is what sets us apart.

At Pharmalys, technological innovation is key to improve the efficiency and effectiveness of our research processes. By implementing state-of-the-art data management systems and adopting the latest advancements in electronic data capture, we ensure that our research operations are not only efficient but also scalable. This integration of technology allows us to handle complex datasets with precision, leading to faster, more reliable outcomes from our clinical trials.

In addition to the core CRO services, we’re committed to sharing our knowledge and expertise with others. We regularly offer capacity-building training sessions for Ethics and Regulatory bodies, as well as clinical research site staff who are eager to enhance their knowledge and expertise. My personal commitment to Pharmalys is deeply rooted in our mission to develop treatments and therapies that have the potential to transform patient care worldwide.

In my role, I am dedicated to expanding Pharmalys’ research footprint and enhancing its visibility on the international stage. By exploring new markets and forging strategic alliances with global partners, I am committed to expanding our network and position in the clinical research sector, ensuring that we continue to contribute to scientific advancements and therapeutic breakthroughs.

Why did I join Pharmalys?

My decision to join Pharmalys was heavily influenced by the opportunity to contribute to the Pharmalys Academy of Clinical research Excellence (PACE). Launched in 2023, PACE represents a significant stride towards enhancing the clinical trials ecosystem. It offers a 9-month curriculum which trains newcomers in clinical research, and an apprenticeship course that enables existing clinical research workers to strengthen their knowledge and expertise. The PACE programme is carefully curated to prepare participants for the high demands of the clinical research sector, ensuring they understand international regulatory landscapes, ethical and quality standards, and gain practical experience through a 6-month internship. Our commitment extends beyond education to enhancing the clinical research ecosystem by providing the sector with job-ready newcomers.

As I look ahead, my ambition is to ensure that Pharmalys not only continues to meet the current needs of the healthcare sector but also innovates to address future challenges. The path we are paving at Pharmalys is geared towards creating sustainable and significant impacts in the field of clinical research, advancing global health initiatives, and improving patient outcomes worldwide. Through every project, partnership, and technological advancement, we are setting the stage for a healthier future, driven by research, innovation, and strategic foresight.

Arthur Makadi, Strategic Projects Coordinator

May 2024

Pharmalys corporate social responsibility commitments

Pharmalys corporate social responsibility commitments

Pharmalys’ approach to corporate social responsibility reflects its long-standing commitment to advancing clinical research while contributing to sustainable and inclusive healthcare systems, particularly across the African continent. Structured around three core...

A recap from the first Pharmalys Voice of 2026

A recap from the first Pharmalys Voice of 2026

On 26 March 26 2026, Pharmalys held its first Pharmalys Voice meeting of the year, bringing together colleagues from across the company for an engaging and interactive virtual session. With a mix of insightful presentations, lively discussions and moments of fun, the...

Women’s economic power benefits everyone

Women’s economic power benefits everyone

Gender equality is a core challenge to be met. More than 95% of women worldwide live in economies that do not provide full legal equality. Even in economies that have modernised their laws, women still face constraints that limit the work they can do, the businesses...

Microplastics and human health: A growing public health concern

Microplastics and human health: A growing public health concern

Developed following the 19th century Industrial Revolution, plastics are synthetic or semi-synthetic polymers, categorised according to the chemical composition of their primary polymer and any side chains. These include acrylics, polyesters, silicones, polyethylenes...

A successful GCLP Audit at Institut Pasteur de Dakar, Senegal

A successful GCLP Audit at Institut Pasteur de Dakar, Senegal

Jeanette Young’s unit at Pharmalys plays a crucial role in advancing global excellence in Good Clinical Laboratory Practice (GCLP) through the delivery of highly specialised ad hoc services, including tailored GCLP trainings and comprehensive gap analyses for...

Delivering excellence under complexity: Lessons learnt from Africa

Delivering excellence under complexity: Lessons learnt from Africa

Pharmalys is an international Clinical Research Organisation (CRO) with a diverse team distributed across Europe, Asia, North America and Africa. Within our global portfolio, we support the execution of numerous clinical trials (CTs) in Africa. Across these projects,...

Jeanette Young Shares GCLP Quality Insights with the TASK Team

Jeanette Young Shares GCLP Quality Insights with the TASK Team

On Friday 13 March 2026, Jeanette Young, Laboratory Solutions & GCLP Team Lead at Pharmalys, delivered an insightful and engaging presentation at TASK HQ  in South Africa. TASK is a global clinical research organisation with an in-house laboratory currently...